Esketamine (a derivative of ketamine) nasal spray formulations can act fast and help reduce dangerous symptoms of major depression and suicidal thoughts found a new study. The findings of this ...

Called Spravato, a brand name for esketamine, and developed by Johnson & Johnson, the drug is a nasal spray designed to treat severe forms of depression that don't respond to other medications.

The FDA has approved Janssen’s antidepressant nasal spray Spravato ... through multiple treatments without relief. Spravato (esketamine) has been touted as a potential blockbuster for Janssen ...

Alert FDA OKs Esketamine Nasal Spray Monotherapy for Depression The expanded indication allows esketamine nasal spray to be used as a standalone treatment in adults with MDD who have not responded ...

We use cookies and other tracking technologies to improve your browsing experience on our website, to show you personalized content and targeted ads, to analyze our website traffic, and to understand ...

Johnson & Johnson has priced its new Spravato nasal spray for treatment-resistant ... has published its final report on Spravato (esketamine) and says the drug would need to be between 25% and ...

Spravato (esketamine) CIII Nasal Spray is indicated, in conjunction with an oral antidepressant, for the treatment of: Treatment-Resistant Depression (TRD) in adults, and Major Depressive Disorder ...